Tina Marriott Larson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Tina Marriott Larson is President and COO of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 506,852 shares of RXRX, which is worth approximately $2.99 Million. The most recent transaction as insider was on Jan 26, 2023, when has been sold 8,000 shares (Class A Common Stock) at a price of $8.07 per share, resulting in proceeds of $64,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 507K
2.74% 3M change
22.6% 12M change
Total Value Held $2.99 Million

Tina Marriott Larson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2023
SELL
Open market or private sale
$64,560 $8.07 p/Share
8,000 Reduced 3.78%
203,654 Class A Common Stock
Jan 26 2023
BUY
Exercise of conversion of derivative security
$8,480 $1.06 p/Share
8,000 Added 3.64%
211,654 Class A Common Stock
Dec 29 2022
SELL
Open market or private sale
$61,600 $7.7 p/Share
8,000 Reduced 3.78%
203,654 Class A Common Stock
Dec 29 2022
BUY
Exercise of conversion of derivative security
$8,480 $1.06 p/Share
8,000 Added 3.64%
211,654 Class A Common Stock
Nov 17 2022
SELL
Open market or private sale
$175,360 $10.96 p/Share
16,000 Reduced 7.28%
203,654 Class A Common Stock
Nov 17 2022
BUY
Exercise of conversion of derivative security
$16,960 $1.06 p/Share
16,000 Added 6.79%
219,654 Class A Common Stock
Nov 15 2022
SELL
Payment of exercise price or tax liability
$17,232 $11.86 p/Share
1,453 Reduced 0.71%
203,654 Class A Common Stock
Oct 27 2022
SELL
Open market or private sale
$171,520 $10.72 p/Share
16,000 Reduced 7.24%
205,107 Class A Common Stock
Oct 27 2022
BUY
Exercise of conversion of derivative security
$16,960 $1.06 p/Share
16,000 Added 6.75%
221,107 Class A Common Stock
Sep 29 2022
SELL
Open market or private sale
$179,200 $11.2 p/Share
16,000 Reduced 7.24%
205,107 Class A Common Stock
Sep 29 2022
BUY
Exercise of conversion of derivative security
$16,960 $1.06 p/Share
16,000 Added 6.75%
221,107 Class A Common Stock
Aug 16 2022
SELL
Open market or private sale
$201,600 $12.6 p/Share
16,000 Reduced 5.14%
295,107 Class A Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$16,960 $1.06 p/Share
16,000 Added 6.75%
221,107 Class A Common Stock
Aug 15 2022
SELL
Payment of exercise price or tax liability
$18,831 $12.96 p/Share
1,453 Reduced 0.7%
205,107 Class A Common Stock
May 16 2022
SELL
Payment of exercise price or tax liability
$8,267 $5.67 p/Share
1,458 Reduced 0.7%
206,560 Class A Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$62,010 $1.06 p/Share
58,500 Added 21.95%
208,018 Class A Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
$16,960 $1.06 p/Share
16,000 Added 9.67%
149,518 Class A Common Stock
Feb 14 2022
BUY
Exercise of conversion of derivative security
$4,240 $1.06 p/Share
4,000 Added 2.91%
133,518 Class A Common Stock
Feb 04 2022
SELL
Payment of exercise price or tax liability
$9,439 $11.4 p/Share
828 Reduced 0.64%
129,518 Class A Common Stock
Feb 04 2022
BUY
Grant, award, or other acquisition
-
82,005 Added 38.62%
130,346 Class A Common Stock
Dec 16 2021
SELL
Open market or private sale
$47,525 $19.01 p/Share
2,500 Reduced 5.0%
47,500 Class A Common Stock
Nov 18 2021
SELL
Open market or private sale
$47,525 $19.01 p/Share
2,500 Reduced 4.76%
50,000 Class A Common Stock
Apr 20 2021
SELL
Other acquisition or disposition
-
52,500 Reduced 100.0%
0 Common Stock
Apr 20 2021
BUY
Other acquisition or disposition
-
52,500 Added 50.0%
52,500 Class A Common Stock
TML

Tina Marriott Larson

President and COO
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX